Changing respiratory health forever

RESPINOR is developing a novel, non-invasive, ultrasound-based medical device for continuous diaphragm monitoring, the main breathing muscle. RESPINOR’s technology is the winner of Horizon 2020 funding both in phase I and II. Our technology has a broad range of potential benefits and represents a technology platform for applications in critical care and in respiratory medicine.

Latest news

28. September 2019

Software/Hardware Engineer in MedTech Startup

21. June 2019

RESPINOR featured in Kapital magazine – Norway’s biggest financial magazine

17. April 2019

First patient enrolled in RESPINOR’s mechanical ventilation WEAN-US study at Hospitalier Pitié-Salpêtrière in Paris, France.

26. March 2019

First patient enrolled in RESPINOR’s weaning study at St.Olav’s hospital in Trondheim, Norway.

8. March 2019

RESPINOR at EIC investor’s day at Nasdaq Stockholm

12. December 2018

DNB Nordic Healthcare Conference 2018, Oslo, Norway

4. December 2018

RESPINOR DXT tested with principal investigator prior to study commencing in Paris, France

15. October 2018

RESPINOR part of Norwegian Business Delegation to Beijing, China

5. September 2018

Market introduction for Norwegian Health Tech Companies to Minneapolis, US

25. June 2018

RESPINOR AS obtained ISO 13485:2016 certification

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 768260.

For patients with chronic respiratory diseases as well as in critical settings, there is a clear need for a non-invasive ultrasound tool to better characterize diaphragm muscle weakness.

EU Eurostars evaluator comment

Quality Policy:
RESPINOR develops innovative products for monitoring of respiratory function. RESPINOR is dedicated to provide uncompromised quality products that are safe and cost-effective to health care systems.
We understand that listening to customer needs and meeting market needs are key to continued product improvement.
RESPINOR is committed to maintaining an effective quality management system compliant with all applicable regulations in countries where our products are developed, manufactured and sold.